52 results
Page 2 of 3
8-K
EX-99.1
qfwuwq3vwctbm3 c6qi
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
sv9el0 n92
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
qhokhju
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
hbwj8
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
elmgk01
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
aobzhgg1ov1z29t6j3u
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
ppaqbtm2 zimxw19rw
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-10.1
t6usv98959z1zj2
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
8-K
EX-99.1
bk7n thi05sbvs4
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-10.1
hihjufyi06rqd
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
nbykykb
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
qemo7 z0g
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
2okeg
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
1tr9j6
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
as7 krc3k
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
lzxew8f5b
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
f9c437ub
7 May 18
Other Events
9:41am
8-K
EX-99.1
t4grbqf2v7bgal9al
30 Apr 18
Other Events
7:15am